One drug - Anzemet at the core of the settlement. BD
WASHINGTON, Sept 10 (Reuters) - A U.S. subsidiary of drugmaker Sanofi-Aventis (SASY.PA: Quote, Profile, Research) has paid about $190 million to federal and state governments to settle charges that it overcharged Medicare for an anti-nausea drug, the Justice Department said on Monday.
The investigation stems from a whistleblower lawsuit by a Florida health care company called Ven-A-Care, which could receive about $32 million of the settlement under U.S. law, the department said.
UPDATE 1-Sanofi-Aventis settles US claims case for $190 mln | Health | Reuters
0 comments :
Post a Comment